Intellia Therapeutics, Inc. (NTLA)
USD 5.98
(-9.8%)
USD 5.98
(-9.8%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -515.29 Million USD | -12.47% |
| 2022 | -458.16 Million USD | -71.05% |
| 2021 | -267.85 Million USD | -96.11% |
| 2020 | -136.58 Million USD | -28.41% |
| 2019 | -106.36 Million USD | -17.06% |
| 2018 | -90.87 Million USD | -30.64% |
| 2017 | -69.55 Million USD | -116.28% |
| 2016 | -32.15 Million USD | -139.83% |
| 2015 | -13.4 Million USD | -156.58% |
| 2014 | -5.22 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -114 Million USD | 18.51% |
| 2024 Q2 | -139.04 Million USD | -21.96% |
| 2023 FY | -515.29 Million USD | -12.47% |
| 2023 Q4 | -139.89 Million USD | -6.7% |
| 2023 Q2 | -132.33 Million USD | -18.2% |
| 2023 Q1 | -111.95 Million USD | -1.7% |
| 2023 Q3 | -131.1 Million USD | 0.93% |
| 2022 Q2 | -98.3 Million USD | 31.85% |
| 2022 Q4 | -110.08 Million USD | -4.32% |
| 2022 FY | -458.16 Million USD | -71.05% |
| 2022 Q1 | -144.24 Million USD | -79.38% |
| 2022 Q3 | -105.53 Million USD | -7.35% |
| 2021 Q1 | -46.42 Million USD | -9.5% |
| 2021 FY | -267.85 Million USD | -96.11% |
| 2021 Q4 | -80.41 Million USD | -11.7% |
| 2021 Q3 | -71.99 Million USD | -4.31% |
| 2021 Q2 | -69.01 Million USD | -48.66% |
| 2020 Q3 | -28.1 Million USD | 14.93% |
| 2020 Q2 | -33.03 Million USD | 0.04% |
| 2020 Q1 | -33.04 Million USD | -11.01% |
| 2020 Q4 | -42.39 Million USD | -50.88% |
| 2020 FY | -136.58 Million USD | -28.41% |
| 2019 Q4 | -29.77 Million USD | -17.54% |
| 2019 FY | -106.36 Million USD | -17.06% |
| 2019 Q1 | -23.8 Million USD | -14.76% |
| 2019 Q2 | -27.46 Million USD | -15.33% |
| 2019 Q3 | -25.32 Million USD | 7.76% |
| 2018 Q1 | -22.43 Million USD | 9.25% |
| 2018 FY | -90.87 Million USD | -30.64% |
| 2018 Q4 | -20.74 Million USD | 13.91% |
| 2018 Q3 | -24.09 Million USD | -2.14% |
| 2018 Q2 | -23.59 Million USD | -5.19% |
| 2017 Q3 | -15.87 Million USD | 0.89% |
| 2017 FY | -69.55 Million USD | -116.28% |
| 2017 Q4 | -24.71 Million USD | -55.69% |
| 2017 Q1 | -12.94 Million USD | -19.65% |
| 2017 Q2 | -16.01 Million USD | -23.7% |
| 2016 Q1 | -6.69 Million USD | -21.91% |
| 2016 Q2 | -6.94 Million USD | -3.76% |
| 2016 FY | -32.15 Million USD | -139.83% |
| 2016 Q4 | -10.82 Million USD | -40.6% |
| 2016 Q3 | -7.69 Million USD | -10.81% |
| 2015 Q3 | -3.3 Million USD | 3.54% |
| 2015 FY | -13.4 Million USD | -156.58% |
| 2015 Q4 | -5.49 Million USD | -66.34% |
| 2015 Q1 | -1.19 Million USD | 71.47% |
| 2015 Q2 | -3.42 Million USD | -186.36% |
| 2014 Q2 | -178 Thousand USD | 0.0% |
| 2014 Q4 | -4.18 Million USD | 0.0% |
| 2014 FY | -5.22 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -237.2 Million USD | -117.233% |
| Alkermes plc | 414.12 Million USD | 224.43% |
| Agenus Inc. | -159.54 Million USD | -222.967% |
| Aptorum Group Limited | -10.52 Million USD | -4796.653% |
| Ardelyx, Inc. | -63.27 Million USD | -714.355% |
| Dyadic International, Inc. | -8.22 Million USD | -6161.329% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -43129.111% |
| Lantern Pharma Inc. | -17.87 Million USD | -2782.332% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -2464.939% |
| Novavax, Inc. | -566.51 Million USD | 9.041% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -606.081% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -526.905% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -2553.606% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -4778.264% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -869.934% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | -35.426% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -2019.963% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -1260.72% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -299.488% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -514.07% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -2837.973% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -1070.85% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -1974.106% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -270.63% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | -82.614% |
| AlloVir, Inc. | -181.33 Million USD | -184.171% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | -151.359% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1661.197% |
| Bicycle Therapeutics plc | -189.94 Million USD | -171.283% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -199.968% |
| ChromaDex Corporation | -5.59 Million USD | -9103.268% |
| Chimerix, Inc. | -93.06 Million USD | -453.689% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -1043.127% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -343.991% |
| CRISPR Therapeutics AG | -222.53 Million USD | -131.552% |
| Precision BioSciences, Inc. | -43.73 Million USD | -1078.185% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -170.478% |
| Fortress Biotech, Inc. | -142.34 Million USD | -262.009% |
| Fortress Biotech, Inc. | -142.34 Million USD | -262.009% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -427.454% |
| ImmuCell Corporation | -5.74 Million USD | -8864.579% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -283.318% |
| Immix Biopharma, Inc. | -16.14 Million USD | -3092.413% |
| Incyte Corporation | 620.52 Million USD | 183.041% |
| Innoviva, Inc. | 176.7 Million USD | 391.604% |
| IO Biotech, Inc. | -91.44 Million USD | -463.511% |
| Jaguar Health, Inc. | -34.29 Million USD | -1402.7% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -203.218% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 4414.947% |
| ContextLogic Inc. | -328 Million USD | -57.101% |
| MiMedx Group, Inc. | 37.11 Million USD | 1488.326% |
| MEI Pharma, Inc. | 14.54 Million USD | 3643.467% |
| NextCure, Inc. | -67.63 Million USD | -661.848% |
| Onconetix, Inc. | -36.03 Million USD | -1329.99% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -1135.295% |
| Opthea Limited | -191.84 Million USD | -168.601% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -18625.428% |
| Vaxcyte, Inc. | -468.04 Million USD | -10.095% |
| PDS Biotechnology Corporation | -43.04 Million USD | -1097.092% |
| Precigen, Inc. | -88.92 Million USD | -479.48% |
| Pharming Group N.V. | -4.87 Million USD | -10460.229% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -207.982% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -1631.721% |
| PureTech Health plc | -146.19 Million USD | -252.459% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -2414.719% |
| Avidity Biosciences, Inc. | -235.59 Million USD | -118.716% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -2019.963% |
| Sangamo Therapeutics, Inc. | -274 Million USD | -88.059% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -1658.372% |
| Acelyrin, Inc. | -422.06 Million USD | -22.088% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -3995971.327% |
| Summit Therapeutics Inc. | -89.73 Million USD | -474.23% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -1290.274% |
| Senti Biosciences, Inc. | -92.72 Million USD | -455.708% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -348.965% |
| Elevation Oncology, Inc. | -45.44 Million USD | -1033.878% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -1403.753% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -12971.657% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -16196.363% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -1460.495% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -5961.534% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -657.825% |
| Seer, Inc. | -103.46 Million USD | -398.044% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -683.605% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -616.349% |
| ESSA Pharma Inc. | -32.13 Million USD | -1503.564% |
| GlycoMimetics, Inc. | -39.27 Million USD | -1211.998% |
| GT Biopharma, Inc. | -13.57 Million USD | -3695.603% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | -135.055% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | -1013.998% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 693.571% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -807.858% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -900.448% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -5085.243% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | -2.176% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -7370.151% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | -916.493% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | -98.449% |
| Aptose Biosciences Inc. | -52.35 Million USD | -884.206% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -3473.255% |
| Soligenix, Inc. | -7.69 Million USD | -6593.882% |
| Century Therapeutics, Inc. | -146.54 Million USD | -251.624% |
| Kura Oncology, Inc. | -165.8 Million USD | -210.783% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -451.361% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -6094.146% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -20664.14% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -7847.116% |
| Autolus Therapeutics plc | -195.02 Million USD | -164.214% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -508.681% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -599.534% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -2338.093% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | -126.965% |
| GRI Bio, Inc. | -11.38 Million USD | -4425.257% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -11311.061% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -292.773% |
| IGM Biosciences, Inc. | -263.46 Million USD | -95.585% |
| INmune Bio, Inc. | -29.74 Million USD | -1632.595% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -365.842% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1253.346% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -3124.728% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -3167.368% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -743.384% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -379.242% |
| Atara Biotherapeutics, Inc. | -276 Million USD | -86.696% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -153.589% |
| Verastem, Inc. | -92.08 Million USD | -459.588% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -993.224% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -179.829% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -335.286% |
| Histogen Inc. | -10.64 Million USD | -4741.595% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -3230.483% |
| Surrozen, Inc. | -45.78 Million USD | -1025.581% |
| Organovo Holdings, Inc. | -15.08 Million USD | -3315.69% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -10023.126% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -769.228% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -904.583% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -1938.335% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -6650.971% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -200.842% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -963.597% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -558.898% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -3285.445% |
| Apollomics, Inc. | -54.83 Million USD | -839.729% |
| Amarin Corporation plc | -67.58 Million USD | -662.4% |
| Mesoblast Limited | -58.79 Million USD | -776.435% |
| Turnstone Biologics Corp. | -59.03 Million USD | -772.901% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -211.298% |
| Synaptogenix, Inc. | -8.31 Million USD | -6097.98% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -3432.778% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -461.986% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -10654.35% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -5734.869% |
| Exelixis, Inc. | 170.88 Million USD | 401.543% |
| Better Therapeutics, Inc. | -38.26 Million USD | -1246.744% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -232.311% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | 0.354% |
| NLS Pharmaceutics AG | -11.8 Million USD | -4264.261% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -6307.573% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -1618.038% |
| Gritstone bio, Inc. | -154.63 Million USD | -233.233% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -648.306% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -2909.341% |
| Avid Bioservices, Inc. | -18.67 Million USD | -2658.813% |
| Insmed Incorporated | -709.62 Million USD | 27.386% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -3184.245% |
| MediWound Ltd. | -15.29 Million USD | -3270.118% |
| OmniAb, Inc. | -69.41 Million USD | -642.291% |
| Alector, Inc. | -151.74 Million USD | -239.588% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -377.196% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -888.132% |
| Zai Lab Limited | -366.57 Million USD | -40.57% |
| Revance Therapeutics, Inc. | -316.77 Million USD | -62.667% |
| Aura Biosciences, Inc. | -84.99 Million USD | -506.289% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | -109.895% |
| Immunic, Inc. | -99.22 Million USD | -419.326% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -259.946% |
| Veracyte, Inc. | -85.79 Million USD | -500.607% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | -82.847% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -3526.256% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -7381.053% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -2641.986% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 189.061% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -1924.48% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 1428.001% |
| TG Therapeutics, Inc. | 20.63 Million USD | 2597.412% |
| Galecto, Inc. | -39.9 Million USD | -1191.294% |
| Calithera Biosciences, Inc. | -42.07 Million USD | -1124.725% |
| Fortrea Holdings Inc. | 63.1 Million USD | 916.626% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -266.899% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -1684.372% |
| XBiotech Inc. | -37.51 Million USD | -1273.743% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -648.306% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -667.716% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -377.537% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1907.21% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -866.92% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | 9.472% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -556.489% |
| Vaxxinity, Inc. | -58.28 Million USD | -784.089% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -396.862% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -2215.589% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -496.291% |
| NexImmune, Inc. | -29.19 Million USD | -1665.15% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -9068.664% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -3433.898% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 112.732% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -1924.003% |
| Scopus BioPharma Inc. | -11.71 Million USD | -4298.604% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -305.543% |
| Ainos, Inc. | -13.2 Million USD | -3801.829% |
| Pluri Inc. | -22.15 Million USD | -2225.53% |
| Prothena Corporation plc | -191.03 Million USD | -169.735% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -273.296% |
| Celularity Inc. | -192.28 Million USD | -167.98% |
| Rallybio Corporation | -78.93 Million USD | -552.829% |
| Cue Biopharma, Inc. | -52.14 Million USD | -888.113% |
| MeiraGTx Holdings plc | -137.06 Million USD | -275.957% |
| Omeros Corporation | -164.53 Million USD | -213.19% |
| Humacyte, Inc. | -100.04 Million USD | -415.049% |
| Immunocore Holdings plc | -59.64 Million USD | -763.872% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -2676.502% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -2004.689% |
| Blueprint Medicines Corporation | -486.27 Million USD | -5.967% |
| CalciMedica, Inc. | -21.87 Million USD | -2255.616% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -590.183% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -291.901% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -200.821% |
| Sana Biotechnology, Inc. | -326.9 Million USD | -57.63% |
| Pulmatrix, Inc. | -14.74 Million USD | -3395.868% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -1341.575% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -479.852% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -662.818% |
| Cytokinetics, Incorporated | -496.2 Million USD | -3.846% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -1397.112% |
| Nutriband Inc. | -4.87 Million USD | -10476.741% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -1081.508% |
| Vor Biopharma Inc. | -126.03 Million USD | -308.844% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 112.147% |
| Evogene Ltd. | -26.39 Million USD | -1852.525% |
| ProKidney Corp. | -151.52 Million USD | -240.077% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -698.467% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -6598.84% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 15.16% |
| CorMedix Inc. | -48.95 Million USD | -952.521% |
| BioLineRx Ltd. | -49.69 Million USD | -936.928% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -351.325% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -1253.464% |
| Atai Life Sciences N.V. | -125.47 Million USD | -310.685% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -531.18% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -532.966% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | -106.954% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1576.288% |
| MediciNova, Inc. | -9.9 Million USD | -5104.82% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -307.754% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -7014.863% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1826.83% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -122.276% |
| Biomea Fusion, Inc. | -126.13 Million USD | -308.523% |
| PTC Therapeutics, Inc. | -349.4 Million USD | -47.478% |
| Mereo BioPharma Group plc | -28.41 Million USD | -1713.383% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -169.66% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | -124.084% |
| Absci Corporation | -115.51 Million USD | -346.081% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1767.876% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -356.547% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | -112.788% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -1945.13% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | -147.743% |
| Allakos Inc. | -196.05 Million USD | -162.828% |
| Imunon, Inc. | -21.03 Million USD | -2350.216% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -365.636% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 580.314% |
| BioAtla, Inc. | -129.68 Million USD | -297.334% |
| NLS Pharmaceutics AG | -11.8 Million USD | -4264.261% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -3152.484% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | -57.227% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -1133.993% |
| XOMA Corporation | -41.84 Million USD | -1131.34% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -389.648% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -324.125% |
| aTyr Pharma, Inc. | -54.91 Million USD | -838.275% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -489.396% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -198.08% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | -102.512% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -2300.498% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -6174.277% |
| Akari Therapeutics, Plc | -16.8 Million USD | -2966.113% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -5826986.417% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 252.645% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -7786.276% |
| UroGen Pharma Ltd. | -65.53 Million USD | -686.272% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -477.176% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -6994.729% |
| Orgenesis Inc. | -53.63 Million USD | -860.719% |
| Entera Bio Ltd. | -8.89 Million USD | -5695.647% |
| GH Research PLC | -41.22 Million USD | -1150.039% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -1904.399% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -520.436% |
| Xencor, Inc. | -138.63 Million USD | -271.678% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -9896.754% |
| Replimune Group, Inc. | -234.77 Million USD | -119.485% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -2297.693% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -3593.313% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -7786.276% |
| Portage Biotech Inc. | -18.25 Million USD | -2723.048% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -7014.863% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -390.936% |
| OncoCyte Corporation | -25.13 Million USD | -1950.012% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -4458.138% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -4397.585% |
| Purple Biotech Ltd. | 22.27 Million USD | 2413.731% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -6759.571% |
| scPharmaceuticals Inc. | -55.39 Million USD | -830.195% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -2626.74% |
| HilleVax, Inc. | -133.34 Million USD | -286.434% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -4176.629% |
| Tharimmune, Inc. | -9.45 Million USD | -5349.804% |
| Genprex, Inc. | -31.07 Million USD | -1558.187% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -173.808% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -1542.257% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -67258.301% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -9360.229% |
| OKYO Pharma Limited | -15.74 Thousand USD | -3271644.976% |
| Savara Inc. | -60 Million USD | -758.718% |
| Curis, Inc. | -48.33 Million USD | -966.149% |
| Daré Bioscience, Inc. | -30.83 Million USD | -1570.859% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -9776.622% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -6981.091% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -1790.976% |
| BeiGene, Ltd. | -1.2 Billion USD | 57.334% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -2484.298% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | -5.769% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -450.219% |
| Erasca, Inc. | -141.52 Million USD | -264.099% |
| bluebird bio, Inc. | -244.26 Million USD | -110.958% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -11282.681% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 365.011% |
| DBV Technologies S.A. | -76.43 Million USD | -574.182% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -11282.681% |
| Moderna, Inc. | -4.23 Billion USD | 87.844% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -1109.348% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -8002.06% |
| Molecular Templates, Inc. | -10.46 Million USD | -4823.476% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -666.38% |
| Travere Therapeutics, Inc. | -376.74 Million USD | -36.775% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -259.561% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -891.078% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -233.431% |
| Cogent Biosciences, Inc. | -208.13 Million USD | -147.581% |
| MacroGenics, Inc. | -168.24 Million USD | -206.276% |
| RenovoRx, Inc. | -11.39 Million USD | -4421.683% |
| Adicet Bio, Inc. | -152.03 Million USD | -238.923% |
| Prime Medicine, Inc. | -191.29 Million USD | -169.374% |
| Aditxt, Inc. | -26.06 Million USD | -1877.141% |
| Adagene Inc. | -23.71 Million USD | -2072.403% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6949.03% |
| Quantum-Si incorporated | -111.17 Million USD | -363.512% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -1528.195% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -3434.773% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 522.321% |
| SciSparc Ltd. | -5.77 Million USD | -8825.879% |
| Vericel Corporation | -6.46 Million USD | -7871.705% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -5852.536% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -2128.808% |
| Generation Bio Co. | -138.56 Million USD | -271.882% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -520.608% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -495.988% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | -113.724% |
| Invivyd, Inc. | -207.78 Million USD | -147.995% |
| Relay Therapeutics, Inc. | -373 Million USD | -38.148% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -5394.384% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 2498.822% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -4909.147% |
| 2seventy bio, Inc. | -216.7 Million USD | -137.787% |
| ADMA Biologics, Inc. | 21.63 Million USD | 2482.077% |
| Clene Inc. | -40.54 Million USD | -1171.068% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -2040.103% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -840.381% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1826.83% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | -47.201% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -1302.839% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 3305.144% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -396.896% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -1415.473% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -202.617% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 24.699% |
| Evaxion Biotech A/S | -22.19 Million USD | -2221.444% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -525.49% |
| Verve Therapeutics, Inc. | -223.12 Million USD | -130.944% |
| Trevena, Inc. | -35.28 Million USD | -1360.244% |
| Surrozen, Inc. | -45.78 Million USD | -1025.581% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -544.557% |
| Cingulate Inc. | -22.75 Million USD | -2164.101% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 6977.883% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -1053.628% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -6158.133% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -402.439% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -602.232% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -730.124% |
| Clearmind Medicine Inc. | -8.74 Million USD | -5794.867% |
| Kronos Bio, Inc. | -121.83 Million USD | -322.959% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -576.27% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -17468.825% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -411.064% |
| Statera Biopharma, Inc. | -98.34 Million USD | -423.969% |
| ImmunityBio, Inc. | -362.25 Million USD | -42.247% |
| Korro Bio, Inc. | -84.53 Million USD | -509.567% |
| Kineta, Inc. | -15.72 Million USD | -3177.307% |
| BioVie Inc. | -32.17 Million USD | -1501.298% |
| Codexis, Inc. | -68.06 Million USD | -657.013% |
| Celularity Inc. | -192.28 Million USD | -167.98% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | -131.479% |
| Celcuity Inc. | -66.23 Million USD | -678.029% |
| Virax Biolabs Group Limited | -6.49 Million USD | -7831.858% |
| Cibus, Inc. | -318.88 Million USD | -61.592% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -1098.351% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -1422.548% |
| IN8bio, Inc. | -30.33 Million USD | -1598.556% |
| Kodiak Sciences Inc. | -277.32 Million USD | -85.81% |
| Annexon, Inc. | -143.72 Million USD | -258.531% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -316.259% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -697.096% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -2097.965% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | -45.674% |
| Eyenovia, Inc. | -25.4 Million USD | -1928.19% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 1678.71% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -9164.491% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -551.171% |
| Arcellx, Inc. | -89.88 Million USD | -473.31% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -1034.702% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -275.557% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -1556.405% |
| Moolec Science SA | -6.65 Million USD | -7644.306% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -742.833% |
| Geron Corporation | -193.94 Million USD | -165.691% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -1091.342% |
| Royalty Pharma plc | 1.49 Billion USD | 134.533% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -213.892% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -5424.211% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -2253.501% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -201.416% |
| Humacyte, Inc. | -100.04 Million USD | -415.049% |
| Structure Therapeutics Inc. | -102.77 Million USD | -401.378% |
| 89bio, Inc. | -151.2 Million USD | -240.792% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -543.053% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -3443.955% |
| Genelux Corporation | -24.16 Million USD | -2032.386% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -1419.002% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -200.024% |
| Notable Labs, Ltd. | -14.65 Million USD | -3415.665% |
| Liquidia Corporation | -73.38 Million USD | -602.184% |
| Mustang Bio, Inc. | -50.72 Million USD | -915.832% |
| Immunovant, Inc. | -282.7 Million USD | -82.269% |
| Quantum-Si incorporated | -111.17 Million USD | -363.512% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -559.758% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -2322.96% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -405.128% |
| Acasti Pharma Inc. | -11.31 Million USD | -4455.26% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -2148.107% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -3124.728% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | -140.729% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -13944.178% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -3143.68% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -1667.298% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -1145.145% |
| PepGen Inc. | -84.76 Million USD | -507.898% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -1639.027% |
| United Therapeutics Corporation | 1.18 Billion USD | 143.488% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -2150.474% |
| Solid Biosciences Inc. | -104.31 Million USD | -393.976% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -1470.62% |
| Immuneering Corporation | -58.41 Million USD | -782.153% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -10023.126% |
| Silo Pharma, Inc. | -3.85 Million USD | -13264.77% |
| Belite Bio, Inc | -31.66 Million USD | -1527.166% |
| XOMA Corporation | -41.84 Million USD | -1131.34% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -663.168% |
| Bionomics Limited | -17.89 Billion USD | 97.12% |
| Apogee Therapeutics, Inc. | -93 Million USD | -454.058% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1544.201% |
| uniQure N.V. | -282.87 Million USD | -82.165% |
| Cassava Sciences, Inc. | -105.95 Million USD | -386.321% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6949.03% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -297.896% |
| Forte Biosciences, Inc. | -32.48 Million USD | -1486.194% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -6101.784% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -1652.989% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -9164.491% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -3526.256% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -5696.951% |
| Altimmune, Inc. | -95.92 Million USD | -437.159% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -601.133% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1544.201% |
| Compugen Ltd. | -12.99 Million USD | -3866.218% |
| Peak Bio, Inc. | -1356.23 USD | -37994266.737% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -938.809% |
| Benitec Biopharma Inc. | -22.49 Million USD | -2191.201% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -112.664% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -1632.304% |
| Zura Bio Limited | -62.63 Million USD | -722.649% |
| PolyPid Ltd. | -22.86 Million USD | -2153.426% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -3065.956% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -1632.304% |
| Instil Bio, Inc. | -159.16 Million USD | -223.738% |
| argenx SE | -425.04 Million USD | -21.231% |
| Immunome, Inc. | -109.53 Million USD | -370.456% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -923.154% |
| Verona Pharma plc | -67.83 Million USD | -659.67% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -1877.325% |
| Shattuck Labs, Inc. | -91.95 Million USD | -460.361% |
| CervoMed Inc. | -7.81 Million USD | -6495.391% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -604.816% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -3768.261% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -969.645% |
| Moolec Science SA | -6.65 Million USD | -7644.306% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -3032.765% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -281.057% |
| AnaptysBio, Inc. | -164.41 Million USD | -213.416% |
| Design Therapeutics, Inc. | -78.19 Million USD | -559.024% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -492.01% |
| NeurAxis, Inc. | -6.66 Million USD | -7631.884% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -1172.355% |
| Lumos Pharma, Inc. | -36.61 Million USD | -1307.361% |
| Achilles Therapeutics plc | -75.25 Million USD | -584.727% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -1877.325% |
| 180 Life Sciences Corp. | -13.47 Million USD | -3723.343% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 10093.404% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -17468.825% |
| Nutriband Inc. | -4.87 Million USD | -10476.741% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -365.148% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -829.306% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -913.634% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -679.575% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -852.072% |
| Palisade Bio, Inc. | -13.07 Million USD | -3842.548% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -1034.777% |
| Beam Therapeutics Inc. | -176.48 Million USD | -191.974% |
| Neurogene Inc. | -55.58 Million USD | -827.066% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -372.077% |
| AEON Biopharma, Inc. | -48.42 Million USD | -964.013% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -432.821% |
| Sesen Bio, Inc. | -25.9 Million USD | -1888.849% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -516.901% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -3993.869% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | -11.884% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -611.345% |
| Athira Pharma, Inc. | -125.46 Million USD | -310.702% |
| Vaccinex, Inc. | -22.88 Million USD | -2151.654% |
| HCW Biologics Inc. | -25.71 Million USD | -1903.685% |
| XOMA Corporation | -41.84 Million USD | -1131.34% |
| Nektar Therapeutics | -137.42 Million USD | -274.962% |
| Arvinas, Inc. | -401.5 Million USD | -28.341% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -5826986.417% |
| Merus N.V. | -156.54 Million USD | -229.161% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -413.95% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -1388.42% |
| Rezolute, Inc. | -70.42 Million USD | -631.708% |
| Clene Inc. | -40.54 Million USD | -1171.068% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -3046.148% |
| BeyondSpring Inc. | -23.11 Million USD | -2129.346% |
| Synlogic, Inc. | -55.16 Million USD | -834.158% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -2774.064% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -4660.634% |
| Peak Bio, Inc. | -1356.23 USD | -37994266.737% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -1172.229% |
| Krystal Biotech, Inc. | -109.72 Million USD | -369.612% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -297.785% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | -50.225% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -10757.482% |
| MannKind Corporation | 8.67 Million USD | 6037.9% |
| Ikena Oncology, Inc. | -75.41 Million USD | -583.256% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -5241.464% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -666.46% |
| Gossamer Bio, Inc. | -183.75 Million USD | -180.417% |
| CohBar, Inc. | -12.38 Million USD | -4059.498% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -915.872% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1767.876% |
| Legend Biotech Corporation | -439.48 Million USD | -17.249% |
| Mural Oncology plc | -194.63 Million USD | -164.743% |
| Biora Therapeutics, Inc. | -67.14 Million USD | -667.453% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -3091.591% |
| Disc Medicine, Inc. | -91.12 Million USD | -465.477% |
| Champions Oncology, Inc. | -7.35 Million USD | -6905.044% |
| REGENXBIO Inc. | -268.12 Million USD | -92.181% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -4707.632% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -824.189% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -1222.594% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -350.599% |
| Vaxart, Inc. | -83.34 Million USD | -518.248% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -5948.011% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -1104.117% |
| Cellectis S.A. | -106.62 Million USD | -383.27% |
| Longeveron Inc. | -21.02 Million USD | -2350.383% |
| Repare Therapeutics Inc. | -116.22 Million USD | -343.36% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | -92.399% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -581.196% |
| Revolution Medicines, Inc. | -487.18 Million USD | -5.769% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -7646.407% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -1072.342% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -590.831% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -639.989% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -4579.784% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 111.963% |
| Denali Therapeutics Inc. | -196.69 Million USD | -161.969% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -5852.536% |
| Veru Inc. | -93.78 Million USD | -449.455% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -2108.8% |
| Cingulate Inc. | -22.75 Million USD | -2164.101% |
| Passage Bio, Inc. | -108.38 Million USD | -375.409% |
| Context Therapeutics Inc. | -25.07 Million USD | -1955.194% |
| Exicure, Inc. | -14.99 Million USD | -3336.19% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -150.064% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -1169.252% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -5203.019% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -179.507% |
| Nuvalent, Inc. | -149.49 Million USD | -244.695% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -6171.41% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -480.734% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -2380.461% |
| OmniAb, Inc. | -69.41 Million USD | -642.291% |
| Anew Medical, Inc. | -1.3 Million USD | -39512.174% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -3934.852% |
| Lipocine Inc. | -17.93 Million USD | -2773.751% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -652.107% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -576.661% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1253.346% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -1203.643% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -2202.051% |
| Sage Therapeutics, Inc. | -579.84 Million USD | 11.134% |
| Ocugen, Inc. | -65.53 Million USD | -686.332% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -448.964% |
| Q32 Bio Inc. | -92.1 Million USD | -459.479% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -2303.522% |
| Alumis Inc. Common Stock | -158.17 Million USD | -225.775% |
| Equillium, Inc. | -14.52 Million USD | -3448.347% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -725.707% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -6419.907% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -2631.45% |
| Galera Therapeutics, Inc. | -46.95 Million USD | -997.508% |
| Evelo Biosciences, Inc. | -108.46 Million USD | -375.071% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -4204.848% |
| Dominari Holdings Inc. | -21.79 Million USD | -2264.154% |
| Edesa Biotech, Inc. | -9.22 Million USD | -5487.168% |
| vTv Therapeutics Inc. | -25.5 Million USD | -1920.591% |
| Bio-Techne Corporation | 206.68 Million USD | 349.311% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | -31.624% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 368.339% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -289.554% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -1242.218% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -241.024% |
| Nkarta, Inc. | -131.65 Million USD | -291.41% |
| BioCardia, Inc. | -11.64 Million USD | -4325.378% |
| Iterum Therapeutics plc | -47.46 Million USD | -985.554% |